参考文献/References:
[1] Spike AJ, Rosen JM. C/EBPß isoform specific gene regulation: it's a lot more complicated than you think[J]. J Mammary Gland Biol Neoplasia, 2020, 25(1): 1-12.
[2] Marta Pulido-Salgado, Jose M Vidal-Taboada, JosepSaura. C/EBPβ and C/EBPδ transcription factors: basic biology and roles in the CNS[J]. Prog Neurobiol, 2015, 132: 1-33.
[3] Gantt K, Cherry J, Tenney R, et al. An early event in adipogenesis, the nuclear selection of the CCAAT enhancer-binding protein {beta}(C/EBP{beta})mRNA by HuR and its translocation to the cytosol[J]. J Biol Chem, 2005, 280(26): 24768-24774.
[4] Bergalet J, Fawal M, Lopez C, et al. HuR-mediated control of C/EBPbeta mRNA stability and translation in ALK-positive anaplastic large cell lymphomas[J]. Mol Cancer Res, 2011, 9(4): 485-496.
[5] Schwartz C, Beck K, Mink S, et al. Recruitment of p300 by C/EBPbeta triggers phosphorylation of p300 and modulates coactivator activity[J]. EMBO J, 2003, 22(4): 882-892.
[6] Belzil VV, Katzman RB, Petrucelli L. ALS and FTD: an epigenetic perspective[J]. Acta Neuropathol, 2016, 132(4): 487-502.
[7] Miller M. Interactions of CCAAT/enhancer-binding protein β with transcriptional coregulators[J]. Postepy Biochem, 2016, 62(3): 343-348.
[8] Bégay V, Baumeier C, Zimmermann K. The C/EBPβ LIP isoform rescues loss of C/EBPβ function in the mouse[J]. Sci Rep, 2018, 8(1): 8417.
[9] Dittmar G, Hernandez DP, Kowenz-Leutz E, et al. PRISMA: protein interaction screen on peptide matrix reveals interaction footprints and modifications- dependent interactome of intrinsically disordered C/EBPβ[J]. iScience, 2019, 13: 351-370.
[10] Zhang YY, Li SF, Qian SW, et al. Phosphorylation prevents C/EBPβ from the calpain-dependent degradation[J]. Biochem Biophys Res Commun, 2012, 419(3): 550-555.
[11] Park YK, Park H. Prevention of CCAAT/enhancer-binding protein beta DNA binding by hypoxia during adipogenesis[J]. J Biol Chem, 2010, 285(5): 3289-3299.
[12] Chio CC, Chang YH, Hsu YW, et al. PKA-dependent activation of PKC, p38 MAPK and IKK in macrophage: implication in the induction of inducible nitric oxide synthase and interleukin-6 by dibutyryl cAMP[J]. Cell Signal, 2004, 16(5): 565-575.
[13] Wegner M, Cao Z, Rosenfeld MG. Calcium-regulated phosphorylation within the leucine zipper of C/EBP beta[J]. Science, 1992, 256(555): 370-373.
[14] Zhao X, Zhuang S, Chen Y, et al. Cyclic GMP-dependent protein kinase regulates CCAAT enhancer-binding protein beta functions through inhibition of glycogen synthase kinase-3[J]. J Biol Chem, 2005, 280(38): 32683-32692.
[15] Buck M, Chojkier M. C/EBPbeta phosphorylation rescues macrophage dysfunction and apoptosis induced by anthrax lethal toxin[J]. Am J Physiol Cell Physiol, 2007, 293(6): C1788-C1796.
[16] Xu M, Nie L, Kim SH, et al. STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPbeta[J]. EMBO J, 2003, 22(4): 893-904.
[17] Zhang J, Li Y, Shan K, et al. Sublytic C5b-9 induces IL-6 and TGF-β1 production by glomerular mesangial cells in rat Thy-1 nephritis through p300-mediated C/EBPβ acetylation[J]. FASEB J, 2014, 28(3): 1511-1525.
[18] Ceseña TI, Cui TX, Subramanian L, et al. Acetylation and deacetylation regulate CCAAT/enhancer binding protein beta at K39 in mediating gene transcription[J]. Mol Cell Endocrinol, 2008, 289(1/2): 94-101.
[19] Wiper-Bergeron N, Salem HA, Tomlinson JJ, et al. Glucocorticoid-stimulated preadipocyte differentiation is mediated through acetylation of C/EBPbeta by GCN5[J]. Proc Natl Acad Sci U S A, 2007, 104(8): 2703-2708.
[20] Leutz A, Pless O, Lappe M, et al. Crosstalk between phosphorylation and multi-site arginine/lysine methylation in C/EBPs[J]. Transcription, 2011, 2(1): 3-8.
[21] Pless O, Kowenz-Leutz E, Knoblich M, et al. G9a-mediated lysine methylation alters the function of CCAAT/enhancer-binding protein-beta[J]. J Biol Chem, 2008, 283(39): 26357-26363.
[22] Kowenz-Leutz E, Pless O, Dittmar G, et al. Crosstalk between C/EBPbeta phosphorylation, arginine methylation, and SWI/SNF/Mediator implies an indexing transcription factor code[J]. EMBO J, 2010, 29(6): 1105-1115.
[23] Lee S, Shuman JD, Guszczynski T, et al. RSK-mediated phosphorylation in the C/EBP{beta}leucine zipper regulates DNA binding,dimerization,and growth arrest activity[J]. Mol Cell Biol, 2010, 30(11): 2621-2635.
[24] Li X, Molina H, Huang H, et al. O-linked N-acetylglucosamine modification on CCAAT enhancer-binding protein beta: role during adipocyte differentiation[J]. J Biol Chem, 2009, 284(29): 19248-19254.
[25] Ndoja A, Reja R, Lee SH, et al. Ubiquitin ligase COP1 suppresses neuroinflammation by degrading c/EBPβ in microglia[J]. Cell, 2020, 182(5): 1156-1169.e12.
[26] Zhang Y, Long X, Ruan X, et al. SIRT2-mediated deacetylation and deubiquitination of C/EBPβ prevents ethanol-induced liver injury[J]. Cell Discov, 2021, 7(1): 93.
[27] Eaton EM, Sealy L. Modification of CCAAT/enhancer-binding protein-beta by the small ubiquitin-like modifier(SUMO)family members, SUMO-2 and SUMO-3[J]. J Biol Chem, 2003, 278(35): 33416-33421.
[28] Friederikeberberich-Siebelt F, IngolfBerberich, Andrulis M, et al. SUMOylation interferes with CCAAT/enhancer-binding protein beta-mediated c-myc repression,but not IL-4 activation in T cells[J]. J Immunol, 2006, 176(8): 4843-4851.
[29] Liu Y, Zhang YD, Guo L, et al. Protein inhibitor of activated STAT 1(PIAS1)is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β(C/EBPβ)during adipogenesis[J]. Mol Cell Biol, 2013, 33(22): 4606-4617.
[30] Wang LP, Wang PX, Xu SW. The cross-talk between PARylation and SUMOylation in C/EBPβ at K134 site participates in pathological cardiac hypertrophy[J]. Int J Biol Sci, 2022, 18(2): 783-799.
[31] Dillon YC, Sarah AS, Garcia-Osta A, et al. A critical role for IGF-II in memoryconsolidation and enhancement[J]. Nature, 2011, 469(7331): 491-497.
[32] Peña-Altamira E, Elisabetta P, Moretto E, et al. The transcriptionfactor CCAAT enhancer-binding protein beta protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms[J]. Eur J Neurosci, 2014, 39(2): 176-185.
[33] PelinKelicen, NiclasTindberg. Lipopolysaccharide induces CYP2E1 in astrocytesthrough MAP kinase kinase-3 and C/EBPbeta and-delta[J]. J Biol Chem, 2004, 279(16): 15734-15742.
[34] Straccia M, Dentesano G, Valente T, et al. CCAAT/enhancer binding protein β regulates prostaglandin E synthase expression and prostaglandin E2 production in activated microglial cells[J]. Glia, 2013, 61(10): 1607-1619.
[35] Wang ZH, Xia Y, Wu Z, et al. Neuronal ApoE4 stimulates C/EBPβ activation, promoting Alzheimer's disease pathology in a mouse model[J]. Prog Neurobiol, 2022, 209: 102212.
[36] Xia Y, Wang ZH, Zhang J, et al. C/EBPβ is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer's disease[J]. Mol Psychiatry, 2021, 26(10): 6002-6022.
[37] Wang ZH, Gong K, Liu X, et al. C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer's disease[J]. Nat Commun, 2018, 9(1): 1784.
[38] Wang HL, Xia L, Chen SD, et al. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease[J]. Proc Natl Acad Sci U S A, 2018, 115(52): E12427-E12434.
[39] Chen C, Zhou Y, Wang H, et al. Gut inflammation triggers C/EBPβ/δ-secretase-dependent gut-to-brain propagation of Aβ and Tau fibrils in Alzheimer's disease[J]. EMBO J, 2021, 40(17): e106320.
[40] Yao Y, Kang SS, Xia Y, et al. A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer's disease pathologies[J]. Brain, 2021, 144(6): 1833-1852.
[41] Wang ZH, Xiang J, Liu X, et al. Deficiency in BDNF/TrkB neurotrophic activity stimulates δ-Secretase by upregulating C/EBPβ in alzheimer's disease[J]. Cell Rep, 2019, 28(3): 655-669.e5.
[42] Wu Z, Wang ZH, Liu X, et al. Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer's disease pathology[J]. Prog Neurobiol, 2020, 185: 101730.
[43] Wang ZH, Xia Y, Liu P, et al. ApoE4 activates C/EBPβ/δ-secretase with 27-hydroxycholesterol, driving the pathogenesis of Alzheimer's disease[J]. Prog Neurobiol, 2021, 202: 102032.
[44] Wu Z, Xia Y, Wang Z, et al. C/EBPβ/δ-secretase signaling mediates Parkinson's disease pathogenesis via regulating transcription and proteolytic cleavage of α-synuclein and MAOB[J]. Mol Psychiatry, 2021, 26(2): 568-585.
[45] Morales-Garcia JA, Gine E, Hernandez-Encinas E, et al. CCAAT/enhancer binding protein β silencing mitigates glial activation and neurodegeneration in a rat model of parkinson's disease[J]. Sci Rep, 2017, 7(1): 13526.
[46] Valente T, Mancera P, Tusell JM, et al. C/EBPβ expression in activated microglia in amyotrophic lateral sclerosis[J]. Neurobiol Aging, 2012, 33(9): 2186-2199.